FFAR1; FFAR4; | |
TSHR; | |
FAAH; TERT; ALOX15; HPGD; ALDH1A1; | |
PPARD; PPARA; PPARG; | |
MAPT; FABP3; LMNA; FABP5; |
Cytochrome P450 Enzymes: | CYP2A6; |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 2 | CYP2A6 | Cytochrome P450 2A6 | P11509 | CHEMBL5282 |
Enzyme_unclassified | FAAH | Anandamide amidohydrolase | O00519 | CHEMBL2243 |
Enzyme_unclassified | TERT | Telomerase reverse transcriptase | O14746 | CHEMBL2916 |
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Enzyme_unclassified | HPGD | 15-hydroxyprostaglandin dehydrogenase [NAD+] | P15428 | CHEMBL1293255 |
Enzyme_unclassified | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P00352 | CHEMBL3577 |
Nuclear hormone receptor subfamily 1 group C | PPARD | Peroxisome proliferator-activated receptor delta | Q03181 | CHEMBL3979 |
Nuclear hormone receptor subfamily 1 group C | PPARA | Peroxisome proliferator-activated receptor alpha | Q07869 | CHEMBL239 |
Nuclear hormone receptor subfamily 1 group C | PPARG | Peroxisome proliferator-activated receptor gamma | P37231 | CHEMBL235 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Small molecule receptor (family A GPCR) | FFAR1 | Free fatty acid receptor 1 | O14842 | CHEMBL4422 |
Small molecule receptor (family A GPCR) | FFAR4 | G-protein coupled receptor 120 | Q5NUL3 | CHEMBL5339 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
Unclassified | FABP3 | Fatty acid binding protein muscle | P05413 | CHEMBL3344 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Unclassified | FABP5 | Fatty acid binding protein epidermal | Q01469 | CHEMBL3674 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0051179; localization | GO:0015908; fatty acid transport | 2.332E-07 | 5.077E-04 | FABP3, PPARA, PPARD, PPARG |
BP | GO:0050896; response to stimulus | GO:0050728; negative regulation of inflammatory response | 2.053E-06 | 2.353E-03 | FFAR4, PPARA, PPARD, PPARG |
BP | GO:0008283; cell proliferation | GO:0048660; regulation of smooth muscle cell proliferation | 3.148E-06 | 2.742E-03 | HPGD, PPARD, PPARG, TERT |
BP | GO:0051179; localization | GO:0010891; negative regulation of sequestering of triglyceride | 6.423E-06 | 5.180E-03 | PPARA, PPARG |
BP | GO:0051179; localization | GO:0010887; negative regulation of cholesterol storage | 9.631E-06 | 5.519E-03 | PPARA, PPARG |
BP | GO:0008152; metabolic process | GO:0010871; negative regulation of receptor biosynthetic process | 9.631E-06 | 5.519E-03 | PPARA, PPARG |
BP | GO:0008152; metabolic process | GO:2001300; lipoxin metabolic process | 9.631E-06 | 5.519E-03 | ALOX15, HPGD |
MF | GO:0140110; transcription regulator activity | GO:0004879; nuclear receptor activity | 8.394E-06 | 5.519E-03 | PPARA, PPARD, PPARG |
MF | GO:0005488; binding | GO:0050543; icosatetraenoic acid binding | 9.631E-06 | 5.519E-03 | FABP3, PPARG |
BP | GO:0008152; metabolic process | GO:0044242; cellular lipid catabolic process | 1.040E-05 | 5.661E-03 | FAAH, FABP3, FABP5, PPARD |
BP | GO:0008152; metabolic process | GO:0019369; arachidonic acid metabolic process | 1.127E-05 | 5.986E-03 | ALOX15, CYP2A6, FAAH |
MF | GO:0060089; molecular transducer activity | GO:0003707; steroid hormone receptor activity | 1.474E-05 | 7.640E-03 | PPARA, PPARD, PPARG |
MF | GO:0060089; molecular transducer activity | GO:0004955; prostaglandin receptor activity | 2.884E-05 | 1.427E-02 | HPGD, PPARG |
MF | GO:0005488; binding | GO:0001223; transcription coactivator binding | 1.212E-04 | 2.964E-02 | PPARA, TERT |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09150 Organismal Systems | 09152 Endocrine system | hsa03320 | PPAR signaling pathway | 1.788E-09 | 6.975E-08 | FABP3, FABP5, PPARG, PPARA, PPARD |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 1.212E-03 | 2.363E-02 | CYP2A6, ALDH1A1 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04024 | cAMP signaling pathway | 1.078E-02 | 8.412E-02 | PPARA, TSHR |
09160 Human Diseases | 09161 Cancers | hsa05202 | Transcriptional misregulation in cancer | 8.897E-03 | 8.412E-02 | HPGD, PPARG |
09100 Metabolism | 09110 Biosynthesis of other secondary metabolites | hsa00232 | Caffeine metabolism | 3.994E-03 | 5.192E-02 | CYP2A6 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00983 | Drug metabolism - other enzymes | 3.619E-02 | 1.168E-01 | CYP2A6 |
09160 Human Diseases | 09161 Cancers | hsa05221 | Acute myeloid leukemia | 4.465E-02 | 1.168E-01 | PPARD |
09150 Organismal Systems | 09152 Endocrine system | hsa04923 | Regulation of lipolysis in adipocytes | 4.389E-02 | 1.168E-01 | TSHR |
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 4.848E-02 | 1.168E-01 | ALOX15 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 5.381E-02 | 1.168E-01 | CYP2A6 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
E00-E89: Endocrine, nutritional and metabolic diseases | Non-insulin dependent diabetes | E11.9 | FFAR1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetes | E23.2, N25.1 | FFAR1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | FFAR1; |